About Paul Berns
Form D filings for Elephas Biosciences from 2022 to 2024 list Paul Berns as director.
Paul Berns first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Paul Berns in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Paul Berns works with at each company, as listed on that company's latest Form D.
Elephas Biosciences Corp · Form D, Jan 9, 2024
SG
Steven Galson
Director
TB
Terrence Brady
Chief Financial Officer
AJ
Andrea Jackson
Director
MA
Maneesh Arora
Executive officer and director